# N-of-1 in ATS and MEPPC

> **NCT06205550** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 10 (estimated)

## Conditions studied

- Andersen Tawil Syndrome
- Multifocal Ectopic Purkinje-related Premature Contractions

## Interventions

- **DRUG:** Flecainide
- **DRUG:** Flecainide + beta-blocker

## Key facts

- **NCT ID:** NCT06205550
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06205550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06205550, "N-of-1 in ATS and MEPPC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06205550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*